Exploiting ETH Zurich research, Micreos is working on a clinical platform that enables the targeted killing of unwanted bacteria only.

The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Stanford spinout DeepVision will use the cash to fund work on its edge computing hardware and software.

Congruent Ventures is among the backers of a $33m series B round for Omnidian, having already taken part in a series A round two years ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Parkwalk Advisors and Cambridge Innovation Capital have backed the pet antibody therapeutics developer, a spinout of Wellcome Sanger Institute.

University of Illinois Urbana-Champaign’s cost management platform developer has increased its valuation to $280m in its most recent round.